Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

JAMA Ophthalmology - United States
doi 10.1001/jamaophthalmol.2017.6135
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Sub-Macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema

Case Medical Research
2019English

The Macular Function and Structure in Patients With Diabetic Macular Edema Before and After Ranibizumab Treatment

Documenta Ophthalmologica
OphthalmologySensory SystemsPhysiology
2016English

Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema

Clinical Ophthalmology
Ophthalmology
2011English

New Strategies for Treatment of Diabetic Macular Edema

Journal of Ophthalmology
Ophthalmology
2018English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Ophthalmology
Ophthalmology
2015English

The Evolving Treatment Options for Diabetic Macular Edema

International Journal of Inflammation
AllergyImmunology
2013English

Diabetic Macular Edema : Overview

Indian Journal of Clinical and Experimental Ophthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy